Award

RISANKIZUMAB 360MG SOLUTION FOR INJECTION HOMECARE

  • Belfast Health & Social Care Trust

UK6: Contract award notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2025/S 000-023636

Procurement identifier (OCID): ocds-h6vhtk-0519f1 (view related notices)

Published 21 May 2025, 10:33am



Scope

Reference

DACPM2025-23

Description

Procurement of RISANKIZUMAB 360MG SOLUTION FOR INJECTION HOMECARE


Contract 1. RISANKIZUMAB 360MG SOLUTION FOR INJECTION HOMECARE

Supplier

Contract value

  • £640,000 excluding VAT
  • £640,000 including VAT

Above the relevant threshold

Award decision date

21 May 2025

Standstill period

  • End: 2 June 2025
  • 8 working days

Earliest date the contract will be signed

16 June 2025

Contract dates (estimated)

  • 17 June 2025 to 30 June 2027
  • 2 years, 14 days

Main procurement category

Goods

CPV classifications

  • 33600000 - Pharmaceutical products

Contract locations

  • UKN - Northern Ireland

Procedure

Procedure type

Direct award


Supplier

SCIENSUS PHARMA SERVICES LIMITED

  • Companies House: 02759609
  • Public Procurement Organisation Number: PXLC-2487-LQPH

107 Station Street

Burton-On-Trent

DE14 1SZ

United Kingdom

Region: UKG24 - Staffordshire CC

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Contract 1. RISANKIZUMAB 360MG SOLUTION FOR INJECTION HOMECARE


Contracting authority

Belfast Health & Social Care Trust

  • Public Procurement Organisation Number: PLQJ-5727-JCLR

Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital

Belfast

BT12 6BA

United Kingdom

Region: UKN06 - Belfast

Organisation type: Public authority - central government

Devolved regulations that apply: Northern Ireland